Legal & General Group’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$464K Sell
33,379
-10,088
-23% -$138K ﹤0.01% 2370
2025
Q4
$600K Buy
43,467
+5,551
+15% +$131K ﹤0.01% 2366
2025
Q3
$927K Sell
37,916
-9,437
-20% -$230K ﹤0.01% 2261
2025
Q2
$1.09M Buy
47,353
+5,055
+12% +$133K ﹤0.01% 2208
2025
Q1
$1.14M Buy
42,298
+7,758
+22% +$292K ﹤0.01% 2141
2024
Q4
$1.85M Buy
34,540
+12,509
+57% +$662K ﹤0.01% 2004
2024
Q3
$1M Buy
22,031
+746
+4% +$32.5K ﹤0.01% 2236
2024
Q2
$892K Buy
21,285
+5,178
+32% +$243K ﹤0.01% 2236
2024
Q1
$606K Buy
16,107
+6,226
+63% +$136K ﹤0.01% 2351
2023
Q4
$106K Hold
9,881
﹤0.01% 2760
2023
Q3
$99.6K Sell
9,881
-313
-3% -$3.61K ﹤0.01% 2829
2023
Q2
$121K Buy
10,194
+5,484
+116% +$73.3K ﹤0.01% 2816
2023
Q1
$57K Buy
4,710
+2,968
+170% +$49.4K ﹤0.01% 2854
2022
Q4
$22.8K Hold
1,742
﹤0.01% 3124
2022
Q3
$24K Buy
1,742
+302
+21% +$4.04K ﹤0.01% 3161
2022
Q2
$18K Sell
1,440
-260
-15% -$3.08K ﹤0.01% 3272
2022
Q1
$24K Buy
1,700
+461
+37% +$7.54K ﹤0.01% 3190
2021
Q4
$24K Hold
1,239
﹤0.01% 3212
2021
Q3
$27K Buy
+1,239
New +$35.6K ﹤0.01% 3166

Other funds holding JANX